vs
Side-by-side financial comparison of Adagene Inc. (ADAG) and Baxter International (BAX). Click either name above to swap in a different company.
Adagene Inc. is a global clinical-stage biotechnology company specializing in the research, development, and commercialization of innovative antibody-based cancer immunotherapies. Leveraging its proprietary next-generation antibody technology platforms, it develops targeted oncology treatments for patients across global markets, with core R&D bases in China and clinical programs covering North America, Asia, and Europe.
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $3.0B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $533.0M | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $3.8B | ||
| Q1 24 | — | $3.6B |
| Q4 25 | — | $-1.1B | ||
| Q3 25 | — | $-46.0M | ||
| Q2 25 | — | $91.0M | ||
| Q1 25 | — | $126.0M | ||
| Q4 24 | — | $-512.0M | ||
| Q3 24 | — | $140.0M | ||
| Q2 24 | — | $-314.0M | ||
| Q1 24 | — | $37.0M |
| Q4 25 | — | 19.4% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 35.3% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | — | 25.0% | ||
| Q3 24 | — | 38.3% | ||
| Q2 24 | — | 37.5% | ||
| Q1 24 | — | 38.6% |
| Q4 25 | — | -24.5% | ||
| Q3 25 | — | 6.1% | ||
| Q2 25 | — | 6.8% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | -25.5% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | — | -5.0% | ||
| Q1 24 | — | 5.2% |
| Q4 25 | — | -37.9% | ||
| Q3 25 | — | -1.6% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | -96.1% | ||
| Q3 24 | — | 5.2% | ||
| Q2 24 | — | -8.2% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | — | $-2.21 | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $0.18 | ||
| Q1 25 | — | $0.25 | ||
| Q4 24 | — | $-0.99 | ||
| Q3 24 | — | $0.27 | ||
| Q2 24 | — | $-0.62 | ||
| Q1 24 | — | $0.07 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
